These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 18082328)

  • 1. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
    Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
    Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
    Carpenter R
    Eur J Surg Oncol; 2008 Jul; 34(7):746-55. PubMed ID: 18296017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitor-induced arthralgia in early breast cancer: what do we know and how can we find out more?
    Din OS; Dodwell D; Wakefield RJ; Coleman RE
    Breast Cancer Res Treat; 2010 Apr; 120(3):525-38. PubMed ID: 20157776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopausal symptoms and adjuvant therapy-associated adverse events.
    Hadji P
    Endocr Relat Cancer; 2008 Mar; 15(1):73-90. PubMed ID: 18310277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer.
    Crew KD; Greenlee H; Capodice J; Raptis G; Brafman L; Fuentes D; Sierra A; Hershman DL
    J Clin Oncol; 2007 Sep; 25(25):3877-83. PubMed ID: 17761973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer.
    Dent SF; Gaspo R; Kissner M; Pritchard KI
    Breast Cancer Res Treat; 2011 Apr; 126(2):295-310. PubMed ID: 21249443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side effects of aromatase inhibitors versus tamoxifen: the patients' perspective.
    Garreau JR; Delamelena T; Walts D; Karamlou K; Johnson N
    Am J Surg; 2006 Oct; 192(4):496-8. PubMed ID: 16978958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
    Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectively nursing patients receiving aromatase inhibitor therapy.
    Wengström Y
    Breast; 2008 Jun; 17(3):227-38. PubMed ID: 18077168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
    Lintermans A; Vanderschueren D; Verhaeghe J; Van Asten K; Jans I; Van Herck E; Laenen A; Paridaens R; Billen J; Pauwels S; Vermeersch P; Wildiers H; Christiaens MR; Neven P
    Eur J Cancer; 2014 Nov; 50(17):2925-31. PubMed ID: 25304297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
    Cella D; Fallowfield LJ
    Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome.
    Morales L; Pans S; Verschueren K; Van Calster B; Paridaens R; Westhovens R; Timmerman D; De Smet L; Vergote I; Christiaens MR; Neven P
    J Clin Oncol; 2008 Jul; 26(19):3147-52. PubMed ID: 18474874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New views on treatment of aromatase inhibitors induced arthralgia.
    Xepapadakis G; Ntasiou P; Koronarchis D; Koufoudakis D; Panousis D; Grosomanidis D; Venizelos V; Georgiadis S
    Breast; 2010 Jun; 19(3):249-50. PubMed ID: 20418100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health.
    Ewer MS; Glück S
    Cancer; 2009 May; 115(9):1813-26. PubMed ID: 19235248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aromatase inhibitors and arthralgia].
    Nagykálnai T; Landherr L; Mészáros E
    Magy Onkol; 2011 Mar; 55(1):32-9. PubMed ID: 21617789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in adjuvant endocrine therapy for postmenopausal women.
    Lin NU; Winer EP
    J Clin Oncol; 2008 Feb; 26(5):798-805. PubMed ID: 18258989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current adjuvant endocrine treatment of breast cancer].
    Dedes KJ; Gabriel N; Fink D
    Gynakol Geburtshilfliche Rundsch; 2008; 48(3):130-7. PubMed ID: 18566529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Abdulhaq H; Geyer C
    Am J Clin Oncol; 2008 Dec; 31(6):595-605. PubMed ID: 19060594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.